Development of a novel stem cell therapy for optic nerve damage

Scheven, Ben (Principal Investigator)
Leadbeater, Wendy (Co-Investigator)
Logan, Ann (Co-Investigator)

Short title	Development of a novel stem cell therapy for optic nerve damage
Status	Finished
Effective start/end date	1/10/13 → 30/09/15

Funding

ROSETREES TRUST

Mesenchymal stromal cell-mediated neuroprotection and functional preservation of retinal ganglion cells in a rodent model of glaucoma
Mead, B., Hill, L. J., Blanch, R. J., Ward, K., Logan, A., Berry, M., Leadbeater, W. & Scheven, B. A., Apr 2016, In: Cytotherapy. 18, 4, p. 487-496 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
56 Citations (Scopus)

306 Downloads (Pure)
Mesenchymal stem cell therapy for retinal ganglion cell neuroprotection and axon regeneration
Mead, B. & Scheven, B., Mar 2015, In: Neural Regeneration Research. 10, 3, p. 371-373 3 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File

10 Citations (Scopus)

372 Downloads (Pure)
Stem cell treatment of degenerative eye disease
Mead, B., Berry, M., Logan, A., Scott, R., Leadbeater, W. & Scheven, B., May 2015, In: Stem Cell Research. 14, 3, p. 243-257 15 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
116 Citations (Scopus)

510 Downloads (Pure)